• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Kyphosis Market

    ID: MRFR/MED/17856-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    US Kyphosis Market Research Report By Type (Postural Kyphosis, Scheuermann's Kyphosis, Congenital Kyphosis), By Diagnostic Test & Diseases (X-ray, Biopsy, Aspirin, Ibuprofen, Naproxen, Spinal Fusion) and By End User (Hospitals, Diagnostic Centres, Research Organizations) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Kyphosis Market Infographic
    Purchase Options

    US Kyphosis Market Summary

    The US Kyphosis market is projected to grow from 125 USD Million in 2024 to 225 USD Million by 2035, indicating a robust growth trajectory.

    Key Market Trends & Highlights

    US Kyphosis Key Trends and Highlights

    • The US Kyphosis market is valued at 125 USD Million in 2024 and is expected to reach 225 USD Million by 2035.
    • The market is anticipated to grow at a compound annual growth rate of 5.49 percent from 2025 to 2035.
    • Increasing awareness regarding spinal health is likely to drive the demand for kyphosis treatment options in the United States.
    • Growing adoption of advanced treatment technologies due to an aging population is a major market driver.

    Market Size & Forecast

    2024 Market Size 125 (USD Million)
    2035 Market Size 225 (USD Million)
    CAGR (2025-2035) 5.49%

    Major Players

    Globus Medical, B. Braun, Medtronic, Aesculap, TST Medical, Ramsay Santé, DePuy Synthes, Stryker, NuVasive, Orthofix, K2M, Brookfield Renewable Partners, Zimmer Biomet, Ra Medical Systems, Soma Ventures

    US Kyphosis Market Trends

    The US Kyphosis Market is experiencing notable trends influenced by demographic shifts and healthcare advancements. One significant trend is the growing prevalence of osteoporosis and spinal deformities among the aging population. As life expectancy increases, so does the incidence of bone-related issues, driving demand for effective treatment options for kyphosis. This has been encouraged by the increasing awareness of spinal health and the importance of proactive treatment measures among healthcare providers and patients alike. Key market drivers include technological advancements in surgical techniques and minimally invasive procedures, which offer patients faster recovery times and reduced hospital stays.

    The introduction of innovative implants and devices tailored for kyphotic corrections is also aiding in the expansion of treatment options available in the US. Additionally, there is an increase in funding and investment in research focused on spinal disorders, particularly from governmental health initiatives aimed at improving patient outcomes. Opportunities to be explored involve the expanding landscape of telehealth services, enabling patients to access specialized care from the comfort of their homes. 

    This has become especially relevant in the context of the COVID-19 pandemic, prompting healthcare providers to adapt to remote consultations and follow-ups for spine-related issues.As states work to improve healthcare access, there is also potential for awareness campaigns that educate the public about early signs of kyphosis and preventive strategies. In recent times, the integration of digital health technologies into treatment plans is becoming more prevalent, encouraging patient engagement and adherence to prescribed therapies.

    The emphasis on personalized medicine is also shaping treatment approaches, allowing for more tailored solutions based on individual patient needs, which is expected to play a vital role in the future growth of the US Kyphosis Market.

    Market Segment Insights

    Kyphosis Market Type Insights

    The US Kyphosis Market, primarily categorized by Type, showcases essential insights that significantly contribute to understanding the dynamics of this evolving sector. Within this market, Postural Kyphosis, Scheuermann's Kyphosis, and Congenital Kyphosis present differentiated characteristics that influence treatment approaches and market demands. Postural Kyphosis is often associated with poor posture and is increasingly prevalent among the younger population due to extensive screen time and sedentary lifestyles. This segment highlights the importance of early intervention and awareness initiatives to educate individuals on maintaining proper posture to avoid long-term complications. 

    On the other hand, Scheuermann's Kyphosis is characterized by a more pronounced structural deformity during adolescence and can lead to chronic pain and functional limitations if not addressed adequately. This segment is significant as it targets a demographic that requires specific surgical or non-surgical treatment options to manage the condition effectively. Given the rising cases among teens, healthcare providers are focusing on developing advanced therapeutic solutions to improve patient outcomes. Lastly, Congenital Kyphosis, resulting from spinal deformities that develop during fetal growth, often necessitates specialized care and management due to its complexity and potential impacts on overall health.

    As awareness regarding congenital disorders increases, the demand for tailored treatment plans and early diagnostic tools in this segment is becoming more pronounced. 

    The growing recognition of these different types of kyphosis reflects the broader trends in the US Kyphosis Market, emphasizing the need for targeted care strategies alongside a robust education outreach. Moreover, increased healthcare spending and advancements in medical technology are enhancing treatment methods across all types, driving market growth. Understanding the distinctions among these categories is crucial for stakeholders looking to navigate the US Kyphosis Market effectively, ensuring that they address both the immediate and long-term needs of patients across various demographics.

    Overall, the diverse Type segment in this market indicates significant opportunities for innovation and improvement in the quality of life for individuals affected by kyphosis.

    Kyphosis Market Diagnostic Test & Diseases Insights

    The Diagnostic Test and Diseases segment of the US Kyphosis Market plays a crucial role in the early identification and management of this spinal condition. This segment features a variety of essential practices, including X-ray, Biopsy, and various medications such as Aspirin, Ibuprofen, and Naproxen. X-ray imaging stands out as a primary diagnostic tool since it provides valuable insights into spinal alignment and curvature, allowing healthcare providers to assess the severity of kyphosis accurately.

    Additionally, Skin Biopsy procedures may occasionally be employed to investigate underlying causes related to bone health, particularly in cases suspected of malignancy.The use of non-steroidal anti-inflammatory drugs (NSAIDs) like Aspirin, Ibuprofen, and Naproxen is significant among patients who experience pain associated with kyphosis, as they offer relief and improve overall patient comfort. Furthermore, Spinal Fusion emerges as a prominent surgical option for severe cases, addressing not only pain but also restoring form and function to the spine.

    The increasing prevalence of osteoporosis in the aging US population is likely to further enhance the importance of these diagnostic tests and treatment options, leading to sustained growth in the market's offerings and advancements in patient care.

    Kyphosis Market End User Insights

    The US Kyphosis Market segment focusing on End Users is pivotal in shaping the overall landscape of the industry. Hospitals represent a significant portion of this segment due to their critical role in patient care, offering specialized treatments and surgical interventions for kyphosis. Diagnostic Centres are increasingly becoming essential as they provide advanced imaging and diagnostic capabilities, enabling timely detection and management of kyphosis, thereby improving patient outcomes.

    Research Organizations play a vital role in exploring innovative treatment methodologies and conducting clinical studies aimed at understanding the causes and long-term effects of kyphosis.The increasing prevalence of age-related conditions and the rising awareness regarding spinal health are driving demand in these areas. Additionally, government health initiatives aimed at improving orthopedic health also contribute to growth in this segment. As the medical community focuses on delivering better patient care, the collaborative efforts between these End Users will further enhance the US Kyphosis Market dynamics and ensure advancements in treatment options for this condition.

    Get more detailed insights about US Kyphosis Market

    Key Players and Competitive Insights

    The US Kyphosis Market is experiencing a dynamic shift as advancements in healthcare technology and increasing prevalence of spinal disorders contribute to competitive activity in the sector. The market is influenced by various factors, including an aging population, rising awareness about spinal health, and innovative treatment options. Key players are focusing on research and development, product launches, and strategic collaborations to enhance their market share. The competitive landscape is characterized by a range of companies that are striving to offer superior products and services, leading to an ever-evolving environment that prioritizes patient care and outcomes.

    Companies are leveraging technological innovations in surgical techniques and minimally invasive procedures to gain a competitive edge and meet the growing demands of healthcare professionals and patients alike.

    Globus Medical is a formidable player in the US Kyphosis Market, showcasing its strengths through cutting-edge product offerings and a strong commitment to addressing spinal deformities. The company's focus on innovation is reflected in its development of advanced spinal implants and surgical instruments, which cater to the specific needs of patients experiencing kyphosis. Globus Medical has established a significant presence in the market by not only delivering effective surgical solutions but also by investing in educational programs that enhance the skillsets of healthcare providers in spinal surgery.

    This combination of innovative product development and comprehensive educational initiatives has significantly bolstered Globus Medical's reputation as a leader in the US Kyphosis Market, enabling it to stand out amidst competition.

    B. Braun also plays a crucial role in the US Kyphosis Market through its extensive range of surgical products and services that address the needs of patients with spinal deformities. The company is known for its commitment to providing high-quality medical devices, which include products designed specifically for spinal surgery. B. Braun's strengths lie in its innovative approach to designing surgical instruments and its focus on enhancing patient outcomes. The company has built a strong market presence in the US through strategic mergers and acquisitions, which have expanded its portfolio and offered new solutions for healthcare providers. B.

    Braun's dedication to research and development, along with its partnerships with healthcare professionals, positions it as a significant contributor to the market, equipping surgeons with the tools necessary for successful kyphosis treatments while continuing to innovate and adapt to the evolving needs of the healthcare landscape.

    Key Companies in the US Kyphosis Market market include

    Industry Developments

    Recent developments in the US Kyphosis Market have seen noteworthy activity, particularly with the increasing focus on advanced treatment solutions for spinal deformities. In March 2023, Globus Medical announced advancements in its spinal fusion technologies, aimed at improving surgical outcomes for kyphosis patients. Meanwhile, Medtronic unveiled a new range of vertebral compression fracture devices in January 2023, which are expected to enhance minimally invasive procedures. Growth factors are also evident, as Stryker’s recent financial reports showcased a significant increase in revenue attributed to the rising demand for kyphosis treatments.

    Regarding mergers and acquisitions, DePuy Synthes completed a strategic acquisition of a spinal device company in February 2023, strengthening its position in the US market. Furthermore, TST Medical’s partnership with major healthcare institutions announced in April 2023 is poised to expand access to kyphosis care. The ongoing enhancements in technologies and surgical methods reflect a market poised for substantial growth, driven by a growing aging population and increasing awareness about spinal health. In recent years, Orthofix has also expanded its product offerings, catering to the evolving needs of patients and healthcare providers alike.

    Market Segmentation

    Kyphosis Market Type Outlook

    • Postural Kyphosis
    • Scheuermann's Kyphosis
    • Congenital Kyphosis

    Kyphosis Market End User Outlook

    • Hospitals
    • Diagnostic Centres
    • Research Organizations

    Kyphosis Market Diagnostic Test & Diseases Outlook

    • X-ray
    • Biopsy
    • Aspirin
    • Ibuprofen
    • Naproxen
    • Spinal Fusion

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 112.56(USD Million)
    MARKET SIZE 2024 125.0(USD Million)
    MARKET SIZE 2035 225.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.489% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Globus Medical, B. Braun, Medtronic, Aesculap, TST Medical, Ramsay Santé, DePuy Synthes, Stryker, NuVasive, Orthofix, K2M, Brookfield Renewable Partners, Zimmer Biomet, Ra Medical Systems, Soma Ventures
    SEGMENTS COVERED Type, Diagnostic Test & Diseases, End User
    KEY MARKET OPPORTUNITIES Increasing elderly population, Advancements in treatment technologies, Growing awareness and education, Enhanced diagnostic imaging solutions, Rising demand for minimally invasive procedures
    KEY MARKET DYNAMICS Aging population, Increased prevalence of osteoporosis, Advancements in treatment technologies, Rising awareness and education, Growing demand for non-invasive treatments
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US Kyphosis Market in 2024?

    The US Kyphosis Market is expected to be valued at 125.0 million USD in 2024.

    What is the projected market size of the US Kyphosis Market by 2035?

    By 2035, the US Kyphosis Market is anticipated to reach a value of 225.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the US Kyphosis Market from 2025 to 2035?

    The US Kyphosis Market is expected to grow at a CAGR of 5.489% from 2025 to 2035.

    Which segment of the US Kyphosis Market is projected to have the largest share in 2024?

    In 2024, the Postural Kyphosis segment is expected to be valued at 45.0 million USD, leading the market.

    What will be the market value of Scheuermann's Kyphosis in 2035?

    The Scheuermann's Kyphosis segment is expected to reach 75.0 million USD by 2035.

    Who are the key players in the US Kyphosis Market?

    Major players in the US Kyphosis Market include Globus Medical, Medtronic, and DePuy Synthes, among others.

    What growth opportunities exist in the US Kyphosis Market?

    There are growth opportunities in addressing the increasing prevalence of kyphosis and advancements in surgical techniques.

    What challenges does the US Kyphosis Market currently face?

    Challenges include high treatment costs and varying patient access to specialized care across different regions.

    What are the market drivers for the US Kyphosis Market?

    Market drivers include an aging population and rising awareness of spinal deformities and their treatments.

    How does the US Kyphosis Market compare with other regions?

    The US Kyphosis Market is significant, with substantial investments and innovations compared to other regions.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials